These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34835217)

  • 1. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland.
    Rzymski P; Poniedziałek B; Fal A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece.
    Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
    Hardt K; Vandebosch A; Sadoff J; Le Gars M; Truyers C; Lowson D; Van Dromme I; Vingerhoets J; Kamphuis T; Scheper G; Ruiz-Guiñazú J; Faust SN; Spinner CD; Schuitemaker H; Van Hoof J; Douoguih M; Struyf F;
    Lancet Infect Dis; 2022 Dec; 22(12):1703-1715. PubMed ID: 36113538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants.
    Abouzid M; Ahmed AA; El-Sherif DM; Alonazi WB; Eatmann AI; Alshehri MM; Saleh RN; Ahmed MH; Aziz IA; Abdelslam AE; Omran AA; Omar AA; Ghorab MA; Islam SMS
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
    Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
    Elife; 2023 Jan; 12():. PubMed ID: 36692910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland.
    Rzymski P; Zeyland J; Poniedziałek B; Małecka I; Wysocki J
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33919672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice.
    Kim E; Khan MS; Ferrari A; Huang S; Sammartino JC; Percivalle E; Kenniston TW; Cassaniti I; Baldanti F; Gambotto A
    Microbiol Spectr; 2023 Jun; 11(3):e0436322. PubMed ID: 37162333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study.
    Al-Qerem W; Al Bawab AQ; Hammad A; Ling J; Alasmari F
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy.
    Della Polla G; Miraglia Del Giudice G; Folcarelli L; Napoli A; Angelillo IF;
    Front Public Health; 2022; 10():1051035. PubMed ID: 36568799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-SARS-CoV-2 Antibodies Level and COVID-19 Vaccine Boosters among Healthcare Workers with the Highest SARS-CoV-2 Infection Risk-Follow Up Study.
    Lorent D; Nowak R; Figlerowicz M; Handschuh L; Zmora P
    Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egyptian hemodialysis patients' willingness to receive the COVID-19 vaccine booster dose: a multicenter survey.
    Abdulaziz HMM; Saleh MA; Elrggal ME; Omar ME; Hawash SA; Attiya AMN; Salem KM; Sabry AA
    J Nephrol; 2023 Jun; 36(5):1329-1340. PubMed ID: 36862285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
    Hyun H; Jang AY; Park H; Heo JY; Seo YB; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ; Yoon SY; Seok JH; Kim J; Park MS; Song JY
    Front Immunol; 2023; 14():1131229. PubMed ID: 36960070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
    Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: A cross-sectional study in Puyang city, China.
    Zhou Y; Li GX; Zhao TS; Du J; Zhang WX; Xie MZ; Chen LY; Zeng J; Wang C; Liu B; Liu YQ; Cui F; Lu QB
    J Med Virol; 2023 Jan; 95(1):e28256. PubMed ID: 36305477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose.
    Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM
    J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
    Kelly JD; Leonard S; Hoggatt KJ; Boscardin WJ; Lum EN; Moss-Vazquez TA; Andino R; Wong JK; Byers A; Bravata DM; Tien PC; Keyhani S
    JAMA; 2022 Oct; 328(14):1427-1437. PubMed ID: 36156706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland.
    Rzymski P; Pazgan-Simon M; Kamerys J; Moniuszko-Malinowska A; Sikorska K; Wernik J; Zarębska-Michaluk D; Supronowicz Ł; Sobala-Szczygieł B; Skrzat-Klapaczyńska A; Simon K; Piekarska A; Czupryna P; Pawłowska M; Brzdęk M; Jaroszewicz J; Kowalska J; Renke M; Flisiak R
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China.
    Zhang XR; Li ZJ; Fu Q; Wang JD; Huang QM; Song WQ; Xu XY; Li ZH; Mao C
    BMC Public Health; 2023 Mar; 23(1):542. PubMed ID: 36949421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.